Angiotensin receptor / neprilysin inhibitors (ARNIs) : the new hope in the management of heart failure

Journal Title: Journal of the Indian Medical Association - Year 2018, Vol 116, Issue 9

Abstract

Heart failure (HF) represents major challenges in cardiovascular disease and despite newer therapeutic advances, mortality still remains high. Inhibition of neurohumoural pathways such as the renin angiotensin aldosterone and sympathetic nervous systems is central in the management of heart failure. LCZ696 (sacubutril/valsartan), a first-in-class angiotensin II AT1 receptor neprilysin inhibitor (ARNI), has a unique mode of action that targets both pathways. The Prospective comparison of ARNI with angiotensin convertase enzyme inhibitor (ACEI) to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF) trial demonstrated that morbidity and mortality can be improved with the ARNI. This trial suggests that sacubitril/valsartan should replace an ACE inhibitor or angiotensin receptor blocker for the treatment of symptomatic patients (NYHA II–IV) with HF with reduced ejection fraction. This review will explore the background of neprilysin inhibition in management of HF, the results of the PARADIGM-HF trial and also guide how to use sacubitril/valsartan in clinical practice.

Authors and Affiliations

Soumya Patra, Rabin Chakraborty

Keywords

Related Articles

Adenoma Sebaceum & Ashleaf Spots

Adenoma sebaceum (Fig 1) are facial angiofibromas usually occurring in patients with tuberous sclerosis and presents as firm, discrete, red or brown telangiectatic papules located in the nasolabial folds, chin, and cheek...

Topical heparin for infusion associated superficial thrombophlebitis : A preventive approach

Maintaining a single indwelling intravenour (IV) catheter for a long duration is limited mainly due to the development of superficial thrombophlebitis. This, we decided to evaluate the efficacy and safety of heparin sodi...

Living with diabetes : a woman’s perspective

Living with diabetes brings multiple challenges with it. This burden is amplified for women, who bear responsibility for management of this condition in themselves, as well as their family members. This person-centred na...

All that wheezes is not Asthma

With worsening air quality, rise in environmental allergens etc. combined with increasing awareness of respiratory diseases, a surge in the incidence of OADs is being witnessed globally. To combat this increasing trend,...

Efficacy of oral Isotretinoin in viral warts

Viral warts are commonly seen in dermatology OPD involving all age groups. Available treatment modalities have their own limitation like unacceptable side effects or inadequate efficacy. The present study was conducted t...

Download PDF file
  • EP ID EP615329
  • DOI -
  • Views 168
  • Downloads 0

How To Cite

Soumya Patra, Rabin Chakraborty (2018). Angiotensin receptor / neprilysin inhibitors (ARNIs) : the new hope in the management of heart failure. Journal of the Indian Medical Association, 116(9), 42-44. https://europub.co.uk/articles/-A-615329